EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy

Ruixuan Zhang, Yunfei Li, Hui Fu, Chengcheng Zhao, Xiuyan Li, Yuming Wang, Yujiao Sun, Yingpeng Li

Acta Pharmaceutica Sinica B · 2025-09 · 15 (9) · 4582-4613

DOI: 10.1016/j.apsb.2025.07.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-09. Verfasst von Ruixuan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 310 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tianjin University, Shandong University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CancerCombination therapyCuproptosisImmunotherapyMetabolic reprogrammingNanomedicinePrecision therapyTumor microenvironment

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • College of Integrated Chinese and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • Experimental Teaching and Practical Training Center, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
  • College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.

Förderung

  • Tianjin University
  • Shandong University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, R., Li, Y., Fu, H., Zhao, C., Li, X., Wang, Y., Sun, Y., & Li, Y. (2025). Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy. Acta Pharmaceutica Sinica B, 15(9), 4582-4613. https://doi.org/10.1016/j.apsb.2025.07.007

Vancouver

Zhang R, Li Y, Fu H, Zhao C, Li X, Wang Y, et al. Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy. Acta Pharmaceutica Sinica B. 2025;15(9):4582-4613. doi:10.1016/j.apsb.2025.07.007

BibTeX
@article{Zhang2025,
  author = {Zhang, Ruixuan and Li, Yunfei and Fu, Hui and Zhao, Chengcheng and Li, Xiuyan and Wang, Yuming and Sun, Yujiao and Li, Yingpeng},
  title = {Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {4582--4613},
  doi = {10.1016/j.apsb.2025.07.007}
}
Kostenlos starten →